Skip to content
Westlake BioPartners
  • People
  • Portfolio
  • About
  • News
  • Contact
Westlake BioPartners
  • People
  • Portfolio
  • About
  • News
  • Contact

Investing in People With Vision

It takes a village to bring life-saving medicines to market, so we invest in entrepreneurs to create companies that turn breakthroughs into treatments for patients in need. 

W Hero Image

We Put People First

Westlake BioPartners is a people-first life science VC firm that crafts companies around world-class entrepreneurs. Immersed in the Los Angeles biotech community we helped catalyze, we’re intentionally scaled to incubate only the most promising companies by complementing their teams with personal attention, hands-on support, and connections to the most impactful innovations of our time. We believe it takes more than just great science to make life-changing medicines and by putting people first, we serve the greatest unmet patient needs.

Get to Know Our People

Our Entrepreneurs Making a Difference

Catherine Pearce, CEO

Catherine Pearce,
CEO

AllRock Bio

Advancing impactful therapies for cardio­pulmonary diseases.

Christian Hordo, CEO

Christian Hordo,
CEO

Borealis Biosciences

Next-generation RNA medicines for kidney disease.

Company We’re Proud to Keep

The Westlake Way

We know people are the first and most valuable asset. Our approach focuses on empowering the right entrepreneurs and guiding them through growth from ideation and preclinical research to clinical and commercial impact for the treatment of patients. We’re intentionally scaled to foster close relationships with our founders, take action instead of offer opinions, and deepen harmonious connections in our entrepreneurial network. By committing to personal attention, we provide each member of our concentrated portfolio with equal and essential access to innovation, capital, and community.

Learn About Our Approach

Happenings in Our Network

Portfolio News
All Rock Bio logo

AllRock Bio Presents Phase 1 Data for Lead Program, ROC-101, at the ERS Congress

September 29, 2025
ROC-101 exhibits favorable pharmacokinetics for once-daily dosing
Read More
Portfolio News
All Rock Bio logo

AllRock Bio Announces $50 Million Series A to Advance Lead Clinical Program for Pulmonary Hypertension

September 16, 2025
Funding to advance first-in-class pan-ROCK inhibitor through Phase 2a testing in...
Read More
Portfolio News

Checking in on the progress of CAR-T for autoimmune conditions with the CEO of Kyverna – the company’s first (and first for the field) registration intended trial will read in the first half of 2026

August 13, 2025
Warner Biddle describes the trajectory of the field, and how neuro-autoimmune...
Read More
See All the Latest

A Complementary Community

Where our visionary founders seized the opportunity to propel the Los Angeles biotech ecosystem, we’ve continued to build an increasingly symbiotic and ever-evolving community. From finding the right entrepreneurs to spearhead company formation, to scaling science through phase-appropriate R&D resources, our network provides unique complementary connections. Drawing from these roots, we support people making medical breakthroughs in California and beyond.

Thinking of the next breakthrough?

Join Our Community
  • People
  • Portfolio
  • About
  • News
  • Contact

© 2025 Westlake BioPartners. All Rights Reserved. Privacy Policy